top of page
Research.jpg

RESEARCH THEMES

Discover the Future of Pharmaceutical Innovation: Lamprou Lab Research Themes

At Lamprou Lab, we’re redefining the boundaries of pharmaceutical science and medical device engineering. Our multidisciplinary team leverages the latest in nano- and microfabrication to create solutions that transform patient care and advance global health.

Why Choose Lamprou Lab?
•    World-Class Expertise: Internationally recognized for pioneering work in printing, bioprinting, and microfluidics.
•    Personalized Research Opportunities: From PhD projects to industry collaborations, we offer tailored pathways for aspiring scientists and partners.
•    Impactful Outcomes: Our technologies address real-world challenges in healthcare, from cancer management to chronic disease diagnostics.

HME.jpg

Additive Manufacturing & 3D/4D Printing

  • Revolutionizing Drug Delivery & Implants: We develop innovative 3D and 4D printing technologies to manufacture personalized drug delivery systems, medical devices, and implants. Imagine tailor-made catheters, vascular grafts, microneedles, and oral dosage forms, engineered for maximum effectiveness and safety.

  • Bioprinting for Tissue Engineering: Our bioprinting research enables the creation of bioresorbable scaffolds, cardiac patches, and wound healing devices, pushing the frontiers of regenerative medicine.

  • Smart Materials: In-house bioinks and filaments, crafted from natural and synthetic polymers, allow us to design drug-loaded implants for diseases ranging from cancer and cardiovascular conditions to diabetes and Parkinson’s.

Recognized as world leaders in 3D Printing/Bioprinting, Lamprou Lab ranks in the top 0.01% of scholars globally for research in printing technologies.

Electrospinning_edited.png

Electrohydrodynamic Processes

  • Medical Nanofibers & Nanoparticles: Using advanced electrospinning and electrospray techniques, we manufacture nanofibers and microparticles for drug delivery and tissue engineering. These technologies enable the development of cardiac patches, oral films, surgical meshes, and long-acting implantable devices.

  • Surface Engineering: Electrospray coatings enhance the performance of stents and implants, improving patient outcomes.

 

Our expertise places us in the top 0.6% of scholars worldwide in nanofiber research.

Microfluidic.jpg

Microfluidics & Lab-on-a-Chip

  • Next-Generation Nanomedicines: We harness microfluidics to produce polymer-based, lipid-based, and hybrid nanomedicines, enabling precise control over size, charge, and surface properties for targeted drug delivery and imaging.

  • Personalized Medicine: Our lab-on-a-chip devices facilitate rapid diagnostics and personalized treatment strategies, including cancer targeting and biologics delivery.

  • Sustainable Manufacturing: Microfluidics offers greener, more efficient production methods, reducing waste and energy consumption.

 

Lamprou Lab is listed among the top 5 UK labs for microfluidics research, with the PI in the top 0.51% globally for microfluidics publications.

Image by Dan-Cristian Pădureț

Point-of-Care Diagnostics & Biosensor Innovation

Harnessing the power of Microelectromechanical Systems (MEMS) and BioMEMS, our research is at the forefront of developing next-generation point-of-care diagnostic platforms, innovative biosensors, and advanced drug delivery systems. By seamlessly integrating cutting-edge 3D printed technologies, such as precision-engineered microneedles and microfluidic solutions, we are driving forward transformative approaches for rapid, personalised healthcare interventions and smart therapeutic delivery.

Image by National Cancer Institute

Diagnostic Technologies: Shaping the Future of Healthcare

At the forefront of medical innovation, our lab reimagines the power of diagnostics through advanced BioMEMS, Microfluidics, and Bioprinting platforms. These state-of-the-art tools not only elevate clinical decision-making but also deliver fast, reliable, and accessible diagnostic solutions that have a tangible impact on lives around the globe. From swiftly identifying food allergens and viral infections to detecting cancer at its earliest stages, our microfluidic devices set new standards in efficiency and accuracy, helping patients and healthcare professionals make informed choices for healthier outcomes worldwide.

Wood Pencil and Notebook

Sustainability & Supply Chain Innovation

Proudly recognised as a leader in sustainable laboratory practices, our lab has achieved Sustainable Lab (S-L) Awards and was distinguished with a Gold Award through our participation in the LEAF pilot lab sustainability programme.

By harnessing cutting-edge 3D printing and microfluidics, we are transforming the pharmaceutical industry’s approach to manufacturing and supply chains. Our research delves deeply into the environmental, social, economic, and legal dimensions of these game-changing technologies, ensuring that their integration delivers not only scientific advances but also a positive, lasting impact on society and the planet. Join us as we help redefine the future of pharmaceuticals with responsible, innovative solutions.

Petri Dish

Areas of Study  

  • End-to-End Innovation: From original ideas to real-world application, our research spans the entire journey-concept development, advanced formulation and manufacturing, comprehensive physicochemical analysis using state-of-the-art instrumentation, sophisticated computational modelling (including FEA and CFD), and thorough in vitro, ex vivo, and in vivo evaluation.

  • Pioneers in Process Excellence: We lead the way in scaling technologies, champion continuous manufacturing, and implement best practices such as Quality by Design (QbD) and Process Analytical Technology (PAT), leveraging cutting-edge tools like NIR, MiR, Raman, and UV probes to ensure optimal product quality.

  • Driving the Digital Frontier: Harnessing the power of machine learning (ML) and artificial intelligence (AI), we apply diverse approaches to transform additive manufacturing and microfluidics, pushing the boundaries of what’s possible in modern healthcare innovation.

  • Unrivalled Characterisation Capabilities: Our suite of advanced nanocharacterisation techniques, including AFM, μCT, ToF-SIMS, and XPS, provides deep, molecular-level insights that enable true precision science.

  • Translating Ideas to Impact: We offer robust support in business strategy and intellectual property, guide the clinical adoption of breakthrough technologies, and provide expert regulatory analysis, ensuring our discoveries make a tangible difference in the healthcare landscape.

If you want to learn more about our research, please don’t hesitate to get in touch.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • SoundCloud

Copyright © 2021-2026 Lamprou Lab | All rights reserved | Last Updated: January 22, 2026

bottom of page